# Docket_Research:
---
# **Sample Data: CMS-2020-0098 - Medicare Coverage of Innovative Technology (MCIT) and Definition of "Reasonable and Necessary**

## Key Terms
"Medicare Coverage"
"Medicare"

## **Overview**
The Centers for Medicare & Medicaid Services (CMS) is proposing a new rule that would establish a Medicare Coverage of Innovative Technology (MCIT) pathway for medical devices that have been approved by the Food and Drug Administration (FDA) and are deemed to be "reasonable and necessary" by CMS. The proposed rule would also establish a definition of "reasonable and necessary" for purposes of Medicare coverage.

## **Docket Details**
- **Docket ID:** CMS-2020-0098
- **Title:** Medicare Coverage of Innovative Technology (MCIT) and Definition of "Reasonable and Necessary"
- **Agency:** Centers for Medicare & Medicaid Services (CMS)
- **Date Posted:** August 31, 2020
- **Comment Period Ended Overall:** November 15, 2021

## **Docket Statistics**
- **Total Comments Received:** 669 comments
- **Number of Attachments:** 7 documents
- **Closed for Comments:** Yes

This rule will primarily impact **medical device manufacturers**, **healthcare providers**, and **patients** who rely on innovative medical technologies for their care. The proposed rule aims to streamline the process for Medicare coverage of innovative technologies and provide patients with faster access to new medical devices that have been approved by the FDA.
